KRMD vs BAX

For growth investors, KORU Medical Systems, Inc.

(KRMD) is the stronger pick with 22. 2% revenue growth year-over-year, versus 5. 7% for Baxter International Inc. (BAX). Analysts rate KORU Medical Systems, Inc. (KRMD) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, KORU Medical Systems, Inc.

(KRMD) delivered a total return of +24. 0%, compared to -74. 3% for Baxter International Inc. (BAX). Over 10 years, the gap is even starker: KRMD returned +1051% versus BAX's -41. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), KORU Medical Systems, Inc.

(KRMD) is the lower-risk stock at 0. 98β versus Baxter International Inc. 's 1. 38β — meaning BAX is approximately 42% more volatile than KRMD relative to the S&P 500. On balance sheet safety, KORU Medical Systems, Inc. (KRMD) carries a lower debt/equity ratio of 21% versus 164% for Baxter International Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), KORU Medical Systems, Inc.

(KRMD) is pulling ahead at 22. 2% versus 5. 7% for Baxter International Inc. (BAX). On earnings-per-share growth, the picture is similar: KORU Medical Systems, Inc. grew EPS 56. 1% year-over-year, compared to -37. 8% for Baxter International Inc.. Over a 3-year CAGR, KRMD leads at 13. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

KORU Medical Systems, Inc.

(KRMD) is the more profitable company, earning -6. 4% net margin versus -8. 5% for Baxter International Inc. — meaning it keeps -6. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BAX leads at -2. 7% versus -7. 2% for KRMD. At the gross margin level — before operating expenses — KRMD leads at 60. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for KRMD: 57.

7% to $7. 00.

In this comparison, BAX (3.

9% yield) pays a dividend. KRMD does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, KORU Medical Systems, Inc.

(KRMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 98), +1051% 10Y return). Both have compounded well over 10 years (KRMD: +1051%, BAX: -41. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: KRMD is a small-cap high-growth stock; BAX is a small-cap income-oriented stock. BAX pays a dividend while KRMD does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.